Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$1.2 - $2.19 $3.92 Million - $7.16 Million
3,270,551 New
3,270,551 $4.35 Billion
Q4 2022

Feb 14, 2023

BUY
$1.63 - $3.52 $5.27 Million - $11.4 Million
3,235,766 New
3,235,766 $5.47 Million
Q3 2022

Nov 14, 2022

BUY
$0.73 - $3.74 $212,507 - $1.09 Million
291,106 Added 9.87%
3,241,701 $10.1 Million
Q2 2022

Aug 15, 2022

BUY
$2.2 - $4.2 $5.38 Million - $10.3 Million
2,445,424 Added 484.08%
2,950,595 $7.02 Million
Q1 2022

May 11, 2022

SELL
$2.83 - $8.69 $49,808 - $152,944
-17,600 Reduced 3.37%
505,171 $2.04 Million
Q4 2021

Feb 11, 2022

BUY
$8.31 - $14.92 $4.34 Million - $7.8 Million
522,771 New
522,771 $4.34 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.